Safety and effectiveness of RZV in adults ≥18 years of age with Systemic lupus erythematosus (SLE) or Multiple sclerosis (MS) (EPI-ZOSTER-041 VS US DB 215104)

18/10/2023
05/09/2025
EU PAS number:
EUPAS107073
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol Amendment_Anonymized_215104

English (2.47 MB - PDF) View document
Study results
Study report
Other information